Document is current
Any future updates will be listed below
-
Authors
Cheng, E.
Yang, P. F.
Khor, S.
Mui, J.
Sarofim, M.
Wijayawardana, R.
Ansari, N.
Koh, C. E.
Morris, D. L.
Ahmadi, N.
-
Funding
Funding for this research was provided by:
University of New South Wales
- License Information
-
More Information
Article History
Received: 23 September 2024
Accepted: 22 December 2024
First Online: 21 January 2025
Declarations
:
: David L. Morris is the owner and director of the company Mucpharm Pty Ltd, Sydney, Australia. All other authors disclose no conflicts of interest. All other authors disclose no conflicts of interest.
: This study was performed in accordance with the ethical standards in the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from all patients to participate in this study and have their data published. The authors affirm that human research participants provided informed consent for publication of the images in Figs. a, b, c, a and b. Ethics approval was granted by both hospital’s Local Health District’s ethics committee.
